Urinary Bladder, Overactive Clinical Trial
Official title:
Overactive Bladder Education
Overactive bladder (OAB) is a common, chronic condition, characterized by urinary "urgency,
with or without urge incontinence, usually with frequency and nocturia." Treatment adherence
is a major barrier to management of OAB and drug continuation is poor. Many factors may play
a role in non-adherence to medication management of OAB including drug cost, side effects,
and a lack of understanding of the disease and treatment process.Studies show that recall of
disease information and treatment is often suboptimal. Literature shows that providing
written materials is an efficacious way to aid in recall. Based on known poor adherence to
OAB medication treatment and the clear role patient education methods have on patient
information recall, the investigators believe that improvement of participant education
through use of a OAB care plan will improve participant understanding and treatment
adherence.
Through this randomized trial, the investigators plan to evaluate whether implementation of
a OAB Care Plan improves understanding of disease and treatment options, treatment success,
and satisfaction.
This is a prospective, randomized, controlled study of OAB counseling in new patients
presenting to the Urogynecology offices of Hartford Hospital. All new patients with a
diagnosis of OAB will be offered participation. All consenting participants will be
randomized 1:1 to one of two groups: 1) Standard Care group or 2) Care Plan group. In the
Standard Care group, participants will be counseled as the physician routinely counsels
patients about OAB, in the Care Plan group, participants will be counseled a printed
"Overactive Bladder Plan of Care" information sheet. At the end of the visit, the
participant will complete a Baseline Survey. The Baseline Survey includes basic demographic
information, a physician satisfaction survey, and a OAB knowledge survey. The participant
will return for follow up as directed by the physician.
At the follow up visit, participants in both groups will complete a Followup Survey. The
Followup Survey will be completed before the participant sees the physician. The Followup
Survey assesses OAB knowledge.
Eight months after the baseline visit, each participant's chart will be reviewed for final
data collection. If a participant progresses to a treatment method where she is satisfied
and would like to remain, this will be documented.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06201013 -
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children
|
N/A | |
Recruiting |
NCT05880862 -
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
|
Early Phase 1 | |
Recruiting |
NCT04807920 -
BOTOX® at the Time of Prolapse Surgery for OAB
|
Phase 4 | |
Terminated |
NCT02385500 -
Fesoterodine on Urgency Episodes in Parkinson's Disease Population
|
Phase 4 | |
Not yet recruiting |
NCT02477241 -
Brain Areas Involved in Bladder Filling and Contraction
|
N/A | |
Completed |
NCT01698138 -
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT00613327 -
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
|
Phase 4 | |
Completed |
NCT00527033 -
A Study of YM178 in Patients With Symptomatic Overactive Bladder
|
Phase 2 | |
Completed |
NCT00368706 -
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
|
Phase 3 | |
Recruiting |
NCT04305743 -
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
|
Phase 4 | |
Active, not recruiting |
NCT03681678 -
Laser Therapy for Treatment of Urogenital Symptoms in Women
|
||
Completed |
NCT01655069 -
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076
|
Phase 3 | |
Completed |
NCT01558856 -
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT01521767 -
Pharmacokinetics and Relative Bioavailability Study
|
Phase 1 | |
Completed |
NCT01194999 -
Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence
|
Phase 4 | |
Completed |
NCT01157377 -
Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence
|
Phase 2 | |
Completed |
NCT01381120 -
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms
|
Phase 4 | |
Completed |
NCT01262391 -
Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents
|
Phase 1 | |
Completed |
NCT04528784 -
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis
|
N/A | |
Completed |
NCT02849418 -
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity
|
Phase 3 |